-
Innovative Biotech Company Announces Agreement To Perform CBD Pill Clinical Study
Friday, September 15, 2023 - 1:47pm | 219Dr. Jim Woody, CEO of 180 Life Sciences Corp. (NASDAQ: ATNF), was recently a guest on Benzinga’s All-Access. 180 Life Sciences is a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain. The company...